COVID-19 in children treated with immunosuppressive medication for kidney diseases

BACKGROUND: Children are recognised as at lower risk of severe COVID-19 compared with adults, but the impact of immunosuppression is yet to be determined. This study aims to describe the clinical course of COVID-19 in children with kidney disease taking immunosuppressive medication and to assess dis...

Descripción completa

Detalles Bibliográficos
Autores principales: Marlais, Matko, Wlodkowski, Tanja, Al-Akash, Samhar, Ananin, Petr, Bandi, Varun Kumar, Baudouin, Veronique, Boyer, Olivia, Vásquez, Luciola, Govindan, Sukanya, Hooman, Nakysa, Ijaz, Iftikhar, Loza, Reyner, Melgosa, Marta, Pande, Nivedita, Pape, Lars, Saha, Anshuman, Samsonov, Dmitry, Schreuder, Michiel F, Sharma, Jyoti, Siddiqui, Sahar, Sinha, Rajiv, Stewart, Heather, Tasic, Velibor, Tönshoff, Burkhard, Twombley, Katherine, Upadhyay, Kiran, Vivarelli, Marina, Weaver, Donald J, Woroniecki, Robert, Schaefer, Franz, Tullus, Kjell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754669/
https://www.ncbi.nlm.nih.gov/pubmed/33355203
http://dx.doi.org/10.1136/archdischild-2020-320616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754669/
https://www.ncbi.nlm.nih.gov/pubmed/33355203
http://dx.doi.org/10.1136/archdischild-2020-320616

Ejemplares similares